Key facts
- Lifeaz’s last known valuation is $60.9M (Feb 2026).
- It has raised $23.4M; the latest was Later Stage VC ($15.3M) in Feb 2026.
- Notable investors include Kima Ventures, XAnge, Siparex, GO Capital, Mirova — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Lifeaz
- ·The full record, as it builds
Funding rounds
No funding rounds for Lifeaz are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lifeaz
Developer of a defibrillator device designed to empower people to save lives. The company's defibrillators provide vocal instructions for usage and enable the user to place the electrodes on the patient's chest, analyze the cardiac rhythm, and decide what therapy to deliver, enabling individuals and companies to be prepared for emergencies and effectively administer aid.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2015
- Employees
- 43
- Website
- lifeaz.co/
- Ownership
- Privately Held (backing)
Lifeaz doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lifeaz shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lifeaz in its N-PORT filings yet. We sweep new filings monthly.